No. | Age/sex | Diagnose | WBC (109/L) | HGB (g/L) | PLT (109/L) | BCR/ABL | Treatment | Time of disease (month) | Survival |
---|---|---|---|---|---|---|---|---|---|
P1 | 43Â Y/M | CML-CP | 290 | 72 | 931 | Positive | Imatinib | 11 | Yes |
P2 | 42Â Y/F | CML-CP | 282 | 77 | 673 | Positive | Imatinib | 11 | Yes |
P3 | 32Â Y/F | CML-CP | 34 | 131 | 505 | Positive | Imatinib | 10 | Yes |
P4 | 33Â Y/M | CML-CP | 165 | 85 | 396 | Positive | Dasatinib | 10 | Yes |
P5 | 27Â Y/M | CML-CP | 288 | 68 | 560 | Positive | Imatinib | 9 | Yes |
P6 | 63Â Y/M | CML-AP | 320 | 77 | 887 | Positive | Imatinib | 21 | No |